melanoma (skin)
Showing 26 - 50 of 328
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Esophageal Cancer Trial in Toronto ([Ga-68]-PNT6555, [Lu-177]-PNT6555)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +4 more
-
Toronto, Ontario, CanadaUniversity Health Network - Princess Margaret Cancer Centre
Aug 16, 2022
Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)
Recruiting
- Melanoma (Skin)
- +3 more
-
Rochester, MinnesotaMayo Clinic
Aug 5, 2022
Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)
Recruiting
- Melanoma (Skin)
- Melanoma, Uveal
-
Oxford, United KingdomChurchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022
Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)
Active, not recruiting
- Melanoma Stage Iii
- +4 more
- Denosumab
- +2 more
-
Chapel Hill, North CarolinaUNC Lineberger Comprehensive Cancer Center
Jul 20, 2022
Melanoma (Skin), Melanoma in Situ Trial in Halifax (Aldesleukin, Saline)
Suspended
- Melanoma (Skin)
- Melanoma in Situ
- Aldesleukin
- Saline
-
Halifax, Nova Scotia, CanadaQueen Elizabeth II Health Sciences Centre
Jul 18, 2022
Melanoma (Skin), Solid Tumor Trial in Australia, United States (PI-88)
Completed
- Melanoma (Skin)
- Unspecified Adult Solid Tumor, Protocol Specific
-
Aurora, Colorado
- +4 more
Jun 21, 2022
Melanoma (Skin) Trial (Emotional Freedom Techniques (EFT))
Not yet recruiting
- Melanoma (Skin)
- Emotional Freedom Techniques (EFT)
- (no location specified)
Jun 14, 2022
Patients With Stage 0-IV Melanoma in Real Clinical Practice
Recruiting
- Melanoma
- +7 more
- surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
-
Moscow, Russian FederationN.N. Blokhin Russian Cancer Research Center
Jun 12, 2022
Melanoma, Melanoma (Skin), Moles Trial in Nizhny Novgorod, Moscow (Non-invasive adhesive system (patch))
Recruiting
- Melanoma
- +11 more
- Non-invasive adhesive system (patch)
-
Nizhny Novgorod, Russian Federation
- +1 more
Jun 12, 2022
Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)
Completed
- Melanoma (Skin)
- sorafenib tosylate
- temozolomide
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 13, 2022
Melanoma (Skin) Trial in Worldwide (interferon alfa-2b, observation)
Active, not recruiting
- Melanoma (Skin)
- interferon alfa-2b
- observation
-
Birmingham, Alabama
- +532 more
Jun 8, 2022
Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients
Recruiting
- Melanoma (Skin)
- +2 more
-
Evora, PortugalHospital Evora
May 30, 2022
Melanoma (Skin), Nevus, Nevus, Spitz Trial in Moscow, Nizhny Novgorod (Mobile phone application "ProRodinki")
Recruiting
- Melanoma (Skin)
- +9 more
- Mobile phone application "ProRodinki"
-
Moscow, Russian Federation
- +1 more
May 29, 2022
Melanoma (Skin) Trial in Philadelphia (89Zr-Df-IAB22M2C PET/CT)
Enrolling by invitation
- Melanoma (Skin)
- 89Zr-Df-IAB22M2C PET/CT
-
Philadelphia, PennsylvaniaPerleman Center for Advanced Medicine
May 31, 2022
Melanoma (Skin) Trial in Strasbourg (Nivolumab 10 MG/ML Intravenous Solution [OPDIVO], Cryotherapy, Ipilimumab Injection)
Completed
- Melanoma (Skin)
- Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
- +2 more
-
Strasbourg, FranceClinique Dermatologique/Radiologie Interventionnelle/Urologie/Gy
Apr 29, 2022
Melanoma Detection in Switzerland With VECTRA
Recruiting
- Melanoma (Skin)
- 3D imaging Total Body Photography Vectra® WB360
- +3 more
-
Basel, SwitzerlandDepartment of Dermatology, University Hospital Basel
Apr 11, 2022
Electrical Impedance Spectroscopy for Early Diagnosis of Skin
Suspended
- Melanoma (Skin)
- +7 more
- Electrical Impedence Spectroscopy DermaSense
-
Thessaloniki, GreeceLaboratory of Medical Physics, AUTH
Apr 4, 2022
To Assess Immunogenicity of Coronavirus Disease 2019 Vaccine in
Recruiting
- Breast Cancer
- +2 more
- COVID-19 Vaccine
-
Kansas City, KansasThe University of Kansas Cancer Center, Westwood Campus
Mar 31, 2022
Breast Carcinoma, Head Neck Cancer, Melanoma (Skin) Trial in Vandoeuvre-les-Nancy (Indocyanine green, Technetium99, Optonuclear
Recruiting
- Breast Carcinoma
- +9 more
- Indocyanine green
- +3 more
-
Vandoeuvre-les-Nancy, FranceInstitut de Cancérologie de Lorraine
Mar 29, 2022
Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)
Active, not recruiting
- Melanoma (Skin)
- Blood sampling
-
Dijon, France
- +3 more
Mar 29, 2022
Melanoma (Skin), Non-Small-Cell Lung Carcinoma Trial in Belgium, Spain, United Kingdom (GAd-PEV, MVA-PEV)
Recruiting
- Melanoma (Skin)
- Non-Small-Cell Lung Carcinoma
- GAd-PEV
- MVA-PEV
-
Charleroi, Belgium
- +6 more
Feb 23, 2022
Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,
Recruiting
- Solid Tumor
- +8 more
- TBio-6517
- Pembrolizumab
-
Phoenix, Arizona
- +10 more
Feb 21, 2022
Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg)
Completed
- Melanoma (Skin)
- Aspirin 81 mg
- Aspirin 325mg
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Feb 16, 2022
Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg, Placebo oral tablet)
Completed
- Melanoma (Skin)
- Aspirin 81 mg
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Feb 16, 2022